ESWT is particularly effective when treating a range of chronic soft tissue injuries that are commonly found in patients’ feet, elbows, shoulders and hips and can cause debilitating pain
New medical treatment is shocking patients and their pain
A 70-year-old woman says she “feels years younger” after undergoing a revolutionary course of medical treatment that is becoming more widely available in the UK and has been proven to be an effective alternative to invasive surgery.
Mrs Jean Dickie from Ayr in Scotland had suffered for three years with excruciating pain caused by Plantar Fasciitis (pain in the underside of the heel) and had almost given up hope of being able to find a cure.
However, she was referred to a Consultant Orthopaedic Foot and Ankle Surgeon in Glasgow and was offered a course of Extracorporeal Shockwave Therapy (ESWT).
ESWT is a relatively new treatment and has been proven to be an effective alternative to invasive surgery. It is becoming an increasingly popular treatment form and is currently available at 100 locations in the UK, 20% of which are NHS hospitals.
The cost of putting a patient through an ESWT treatment course is considerably less than the cost of invasive surgery. Out of 80% of orthopaedic outpatient appointments, only 20% require surgery. Surgeons prefer not to operate on patients such as Mrs Dickie because the outcomes from surgery for plantar fasciitis often do not prove too successful. ESWT has the potential to save healthcare providers considerably because patients like Mrs Dickie will not require any further treatment from a GP or hospital.
ESWT is particularly effective when treating a range of chronic soft tissue injuries that are commonly found in patients’ feet, elbows, shoulders and hips and can cause debilitating pain.
Having completed a course of three, 10-minute ESWT treatment sessions, Mrs Dickie was rendered totally pain free within a month and is enjoying her retirement again.
She said: “I endured three years of terrible pain with my heel – it was absolutely awful. The pain was so bad that I was often in tears. But this shockwave therapy treatment has taken away all of the pain and I feel years younger.”
“It’s a wonderful result because your mobility is so important when you get older. If you have any pain and discomfort it can knock your confidence and general appetite for life. But this treatment has had a really positive impact on me and I’m so thankful.”
Patients can access Extracorporeal Shockwave Therapy treatment services in both the NHS and private settings. To locate a clinic, patients should speak to their doctor or visit www.spectrumtechnologyuk.com and click on the ‘find a clinician’ tab.
Mr Pal Ramesh, one of the UK’s top Orthopaedic specialists, runs an ESWT clinic at the NHS New Malden Diagnostic Clinic. He said: “Extracorporeal Shockwave Therapy is just as effective as traditional surgery but it has lots of other benefits. The treatment only takes minutes to perform, it doesn’t involve anaesthetic, the patient isn’t put in plaster and doesn’t face a long rehabilitation that can mean six months off work.”
During the ESWT treatment process, low-energy shockwaves are passed through the skin to initiate an inflammatory response in the injured tissue. This prompts the body to respond naturally by increasing blood circulation, the number of blood vessels and therefore metabolism in the injured tissue. This accelerates the body’s natural healing response by increasing cell generation and dissolving calcium deposits.
“It has always been very difficult to treat some chronic conditions because we haven’t had a truly effective solution apart from invasive surgery,” Mr Ramesh added. “But Extracorporeal Shockwave Therapy is successfully filling that void and it’s great that this treatment is becoming more readily available.”
For media enquiries relating to this press release, please contact Lindsey Webb on
email@example.com or telephone 07734 113259
• Spectrum Technology UK Ltd is the exclusive distributor for the low-energy Swiss DolorClast Extracorporeal Shockwave Therapy device in the UK
• NICE advised that Extracorporeal Shockwave Therapy (ESWT) is considered a safe treatment option for the treatment of Plantar Fasciitis, Achilles Tendonopathy and Tennis Elbow
• Spectrum Technology’s Swiss DolorClast device has amassed more clinical trial data between levels one and two than any other Extracorporeal Shockwave Therapy device in the world
• The Swiss DolorClast device is widely used in top-flight sport to treat and manage injuries. The device is used by a number of football teams in the English Premier League and was also used by athletes at the last three Olympic Games
• The Swiss DolorClast is the only rESWT device to be actively promoted in the UK that administers low-energy impulses during treatment. As yet, there have been no reported ruptures as a result of using the Swiss DolorClast
• The Swiss DolorClast low-energy radial Extracorporeal Shockwave Therapy device was designed and continues to be manufactured by Electro Medical Systems (EMS) in Switzerland
• The Swiss DolorClast device delivers shockwaves to the injured area of the body by converting kinetic energy into a shockwave – an action that is clearly illustrated by Newton’s Cradle
• Spectrum Technology is proud to conduct its clinical trials with the support of some of the UK’s leading medical professionals. This list includes Professor Nicola Maffulli, one of the most pre-eminent sports medicine and orthopaedic consultants in the UK
• For more information about Spectrum Technology and its Swiss Dolorclast device, visit the website at www.spectrumtechnologyuk.com
This press release was distributed by ResponseSource Press Release Wire on behalf of The Milk Round in the following categories: Health, Medical & Pharmaceutical, for more information visit https://pressreleasewire.responsesource.com/about.